Modern possibilities of infusion therapy in patients with diabetic ketoacidosis
Pathophysiological rationale and prospects for using xylitol in the nutritional support of cancer patients
Japanese experience in the treatment of patients with acute ischemic stroke. Interview with Professor Yukito Shinohara
The Academy of Stroke, Annual Scientific and Educational Forum, traditionally dedicated to World Stroke Day was held in Kyiv October 31 – November 1, 2019. Yukito Shinohara, Professor Emeritus of Tokai University School of Medicine, former president of the Japan Stroke Society and the Asia Pacific Stroke Organization, Chairman of ...The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy
Resume. The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therapy (TLT). These studies indicate greater efficacy of using Edaravon in combination with TLT in the treatment of ischemic stroke. When using the drug Xavron side effects of ...School of endocrinologist: some aspects of infusion treatment of diabetes
The principles of the educational project “School of Endocrinologist”, which has become traditional, include the originality of the submission of theoretical material, its practical orientation and interactive communication. In accordance with these principles, the latest recommendations, current views on some pathological conditions and methods of their treatment were presented to ...L-arginine in norm and pathology
Abstract. L-arginine is a conditionally essential amino acid, which is the cellular regulator of many vital functions of the body. He is involved in the regulation of the tone of the smooth muscle component of the blood vessels wall, bronchi, and intestines. L-arginine is a substrate for the nitric oxide ...Usage of the new edaravone free radical scavenger (XAVRON) in the treatment of acute ischemic stroke
The purpose of the study is to evaluate the effectiveness of use of the drug edaravone for treatment of patients with acute cerebral infarction comparing to citicoline. The results of the treatment of ischemic stroke by intravenous administration of edaravone (Xavron) and citicoline indicated a more pronounced elimination of neurological ...Perspective Treatment Goals for Brain Protection in Case of Acute Ischemia
Abstract. Ischemic stroke initiates a cascade of biochemical reactions, among which the processes of free radical oxidation occupy a key place. The most important place in management this disease takes reperfusion therapy, the conduct of which is closely related to the problem of neuroprotection. Use of antioxidants is a promising ...Brain protection in acute ischemia
From 15 to 16 million people suffer a stroke every year, of which 100-110 thousand are residents of Ukraine. This vascular desiase ranks first among causes of disability and is one of the leading causes of death. One third of patients die during the first year after stroke, one out ...